Climb Share Price
NASDAQ: CLYM | Small Cap | HealthcareClimb Stock Performance
Climb Share Price Today
As of 19 November 2026, Climb Bio, Inc.'s share price is $9.45. The stock opened at $9.70, compared to its previous close of $9.75. During today's trading session, Climb Bio, Inc.'s share price traded between $9.40 and $9.88, with an average price of $9.64. Over the past 52 weeks, the stock has recorded a high of $18.32 and a low of $1.64. In terms of performance, Climb Bio, Inc.'s share price has declined by 13.74% over the last six months and is up 402.39% on a year-on-year basis.
Climb Share Price Chart
Climb Quarterly Profit & Loss
All figures in USD
Climb Annual Profit & Loss
All figures in USD
Climb Balance Sheet
All figures in USD Million
Climb Cash Flow
All figures in USD Million
About Climb
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Climb Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $10.29 | $9.43 | -7.91% |
Oct 2026 | $11.38 | $10.24 | -11.03% |
Sep 2026 | $13.29 | $11.51 | -23.60% |
Aug 2026 | $11.67 | $15.06 | +26.54% |
Jul 2026 | $12.98 | $11.90 | -8.77% |
Jun 2026 | $10.94 | $13.05 | +19.18% |
May 2026 | $8.61 | $10.95 | +23.45% |
Apr 2026 | $7.10 | $8.87 | +29.49% |
Mar 2026 | $6.79 | $6.85 | -4.60% |
Feb 2026 | $4.50 | $7.18 | +60.63% |
Jan 2026 | $4.10 | $4.47 | +11.75% |
Dec 2025 | $1.86 | $4.00 | +112.77% |